We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gait Characteristics Following a Fall

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2012 by Hadassah Medical Organization.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01631604
First Posted: June 29, 2012
Last Update Posted: April 27, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Hadassah Medical Organization
  Purpose
The purpose of this study is to quantify the safety degree of the patient's gait, to detect the reason for the fall and quantify the biomechanical parameters related to fall. This study also aims to evaluate the effect of different rehabilitation treatments and their effect on the risk of falling.

Condition Intervention
Motor Impairments Orthopaedic Injuries Neurological Conditions Device: Walking aids and devices Drug: Muscle/nerve injection Procedure: Corrective surgery Other: Physical therapy treatment

Study Type: Interventional
Study Design: Intervention Model: Factorial Assignment
Primary Purpose: Treatment
Official Title: Quantification of Gait Parameters and Muscle Activation Patterns Following a Fall

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:
  • Gait kinematics
    Joint angles, velocities and accelerations


Secondary Outcome Measures:
  • Muscle activation patterns
    Dynamic EMG of various muscles.


Study Start Date: June 2012
Estimated Study Completion Date: June 2017
Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Walking aids and devices
    Walking aids, e.g. braces, canes,orthoses, prosthetics, etc.
    Drug: Muscle/nerve injection
    Injection to muscle or nerve
    Other Names:
    • Botulinum toxin
    • Marcaine
    Procedure: Corrective surgery
    correction of spinal and bony deformities, muscle transfer, tendon elongation etc.
    Other Names:
    • Knee arthroscopy, meniscectomy and chondroplasty
    • Anterior cruciate ligament reconstruction
    • Knee replacement
    • Repair of femoral neck fracture
    • Repair of trochanteric fracture
    • Debridement of skin/muscle/bone/fracture
    • Knee arthroscopy repair of both menisci
    • Hip replacement
    • Repair of ankle fracture (bimalleolar type)
    • Lumbar spinal fusion
    • Low back intervertebral disc surgery
    • Repair of femoral shaft fracture
    Other: Physical therapy treatment
Detailed Description:

In this study, patients suffering from motor disabilities as a result of orthopedic or neurologic impairments will be tested at the gait and motion laboratory. Each patient will be secured with a ceiling-mounted safety harness and will walk on the path wearing passive light-reflecting markers and surface electrodes. High-speed cameras will record the subject's movements and the markers will be tracked to produce data of joint angles, velocities and accelerations. Dynamic EMG will be recorded from various muscles.

During the examination, the gait of the subjects will be disturb by either (i) a visual or sound signal that requires the subject to stop immediately, or (ii) walking different terrains, or (iii) tying a string to the foot and pulling it shortly to induce a trip.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   5 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Individuals suffering from gait impairment following injury to the central or peripheral nervous system, as well as following orthopedic injuries. The subjects will be able to understand and independently sign a consent form.

Exclusion Criteria:

  • Subjects who are unable to understand and independently sign a consent form
  • Subjects who are wheelchair bound.
  • Pregnant women.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01631604


Locations
Israel
Hadassah Medical Center
Jerusalem, Israel, 91240
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

Responsible Party: Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01631604     History of Changes
Other Study ID Numbers: Fall-HMO-CTIL
First Submitted: June 28, 2012
First Posted: June 29, 2012
Last Update Posted: April 27, 2017
Last Verified: June 2012

Keywords provided by Hadassah Medical Organization:
risk of falling
gait patterns
muscle activity
fall prevention
motor impairment

Additional relevant MeSH terms:
Botulinum Toxins
Acetylcholine Release Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cholinergic Agents
Neurotransmitter Agents
Physiological Effects of Drugs


To Top